Ortoma: Creating a good foundation for growth - Redeye

Redeye makes minor revisions based on the Q2 report. We have changed the timing of some milestones to 2025e, but expect that they will receive the full amount by mid-2025e. The progress is evident in our view, even if it is still early in the commercialization process, and the recently announced milestone coming in Q3 is a good sign of progress. The outlook is still very promising. We nudge our fair value range upwards while increasing our Base case to SEK19.5 (18.7) per share

Länk till analysen i sin helhet: https://www.redeye.se/research/1023904/ortoma-creating-a-good-foundation-for-growth?utm_source=finwire&utm_medium=RSS